Clinical Outcomes in Patients with Intermediate Coronary Stenoses: MINIATURE Investigators (Korea MultIceNter TrIal on Long-Term Clinical Outcome According to the Plaque Burden and Treatment Strategy in Lesions with MinimUm Lumen ARea lEss Than 4 mm(2) Using Intravascular Ultrasound)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Young Joon | - |
dc.contributor.author | Choi, Yun Ha | - |
dc.contributor.author | Park, Soo Young | - |
dc.contributor.author | Nam, Chang Wook | - |
dc.contributor.author | Cho, Jang Hyun | - |
dc.contributor.author | Kang, Won Yu | - |
dc.contributor.author | Lee, Sang Rok | - |
dc.contributor.author | Lee, Sung Yun | - |
dc.contributor.author | Kim, Sang Wook | - |
dc.contributor.author | Lim, Sang Yeob | - |
dc.contributor.author | Yun, Kyung Ho | - |
dc.contributor.author | Kim, Jung Sun | - |
dc.contributor.author | Kim, Jin Won | - |
dc.contributor.author | Kang, Woong Chol | - |
dc.contributor.author | Kim, Ki Seok | - |
dc.contributor.author | Choi, Jin Ho | - |
dc.contributor.author | Chung, Joong Wha | - |
dc.contributor.author | Kim, Soo Joong | - |
dc.contributor.author | Ahn, Youngkeun | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.date.accessioned | 2021-09-05T09:09:56Z | - |
dc.date.available | 2021-09-05T09:09:56Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-05 | - |
dc.identifier.issn | 1738-5520 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/98633 | - |
dc.description.abstract | Background and Objectives: We evaluated the two-year clinical outcomes in patients with angiographically intermediate lesions according to the plaque burden and treatment strategy. Subjects and Methods: We prospectively enrolled patients with angiographically intermediate lesions (diameter stenosis 30-70%) with an intravascular ultrasound (IVUS) minimum lumen area (MLA) <4 mm(2) with 50-70% plaque burden of 16 Korean percutaneous coronary intervention centers. Patients were divided into medical therapy group (n=85) and zotarolimus-eluting stent group (ZES; Resolute) group (n=74). We evaluated the incidences of two-year major adverse cardiovascular events (MACE). Results: A two-year clinical follow-up was completed in 143 patients and MACE occurred in 12 patients. There were no significant differences in the incidences of death (1.3% vs. 3.0%, p=0.471), target vessel-related non-fatal myocardial infarction (0.0% vs. 0.0%, p=1.000) and target vessel revascularizations (7.8% vs. 4.5%, p=0.425) between medical and ZES groups. Independent predictors of two-year MACE included acute myocardial infarction {odds ratio (OR)=2.87; 95% confidence interval (CI) 1.43-6.12, p=0.014}, diabetes mellitus (OR=2.46; 95% CI 1.24-5.56, p=0.028) and non-statin therapy (OR=2.32; 95% CI 1.18-5.24, p=0.034). Conclusion: Medical therapy shows comparable results with ZES, and myocardial infarction, diabetes mellitus and non-statin therapy were associated with the occurrence of two-year MACE in patients with intermediate lesion with IVUS MLA <4 mm(2) with 50-70% of plaque burden. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC CARDIOLOGY | - |
dc.subject | FRACTIONAL FLOW RESERVE | - |
dc.subject | C-REACTIVE PROTEIN | - |
dc.subject | FUNCTIONAL-SIGNIFICANCE | - |
dc.subject | DIABETES-MELLITUS | - |
dc.subject | LDL-CHOLESTEROL | - |
dc.subject | ARTERY STENOSES | - |
dc.subject | STATIN THERAPY | - |
dc.subject | ATHEROSCLEROSIS | - |
dc.subject | DISEASE | - |
dc.subject | SEVERITY | - |
dc.title | Clinical Outcomes in Patients with Intermediate Coronary Stenoses: MINIATURE Investigators (Korea MultIceNter TrIal on Long-Term Clinical Outcome According to the Plaque Burden and Treatment Strategy in Lesions with MinimUm Lumen ARea lEss Than 4 mm(2) Using Intravascular Ultrasound) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lim, Sang Yeob | - |
dc.contributor.affiliatedAuthor | Kim, Jin Won | - |
dc.identifier.doi | 10.4070/kcj.2014.44.3.148 | - |
dc.identifier.scopusid | 2-s2.0-84902303969 | - |
dc.identifier.wosid | 000342411700004 | - |
dc.identifier.bibliographicCitation | KOREAN CIRCULATION JOURNAL, v.44, no.3, pp.148 - 155 | - |
dc.relation.isPartOf | KOREAN CIRCULATION JOURNAL | - |
dc.citation.title | KOREAN CIRCULATION JOURNAL | - |
dc.citation.volume | 44 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 148 | - |
dc.citation.endPage | 155 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001876483 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | FRACTIONAL FLOW RESERVE | - |
dc.subject.keywordPlus | C-REACTIVE PROTEIN | - |
dc.subject.keywordPlus | FUNCTIONAL-SIGNIFICANCE | - |
dc.subject.keywordPlus | DIABETES-MELLITUS | - |
dc.subject.keywordPlus | LDL-CHOLESTEROL | - |
dc.subject.keywordPlus | ARTERY STENOSES | - |
dc.subject.keywordPlus | STATIN THERAPY | - |
dc.subject.keywordPlus | ATHEROSCLEROSIS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordAuthor | Coronary artery disease | - |
dc.subject.keywordAuthor | Atherosclerotic plaque | - |
dc.subject.keywordAuthor | Intravascular ultrasonography | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.